share_log

Amarin Corp Analyst Ratings

Amarin Corp Analyst Ratings

Amarin Corp 分析師評級
Benzinga ·  2023/07/20 08:04
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
07/20/2023 -7.41% Goldman Sachs $1.5 → $1 Maintains Sell
07/19/2023 15.74% Northland Capital Markets $2 → $1.25 Maintains Market Perform
01/06/2023 177.78% Jefferies $1.3 → $3 Upgrades Hold → Buy
10/19/2022 85.19% SVB Leerink $3 → $2 Maintains Market Perform
05/24/2022 38.89% Goldman Sachs $1.75 → $1.5 Maintains Sell
05/06/2022 JP Morgan Downgrades Neutral → Underweight
05/05/2022 177.78% HC Wainwright & Co. $10 → $3 Downgrades Buy → Neutral
05/05/2022 177.78% SVB Leerink $10 → $3 Downgrades Outperform → Market Perform
02/16/2022 825.93% SVB Leerink $11 → $10 Maintains Outperform
01/31/2022 918.52% SVB Leerink $12 → $11 Maintains Outperform
09/09/2021 1011.11% SVB Leerink → $12 Initiates Coverage On → Outperform
05/12/2021 362.96% Goldman Sachs $6 → $5 Downgrades Neutral → Sell
02/01/2021 1381.48% SVB Leerink $12 → $16 Maintains Outperform
09/28/2020 1011.11% SVB Leerink $9 → $12 Maintains Outperform
08/26/2020 1844.44% Piper Sandler → $21 Initiates Coverage On → Overweight
05/04/2020 918.52% Aegis Capital $9 → $11 Maintains Buy
05/04/2020 733.33% SVB Leerink $7 → $9 Maintains Outperform
04/01/2020 455.56% Citigroup $24 → $6 Maintains Buy
03/31/2020 640.74% Stifel $24 → $8 Maintains Hold
03/31/2020 Oppenheimer Upgrades Underperform → Perform
03/31/2020 270.37% Goldman Sachs $27 → $4 Downgrades Buy → Neutral
03/31/2020 270.37% Jefferies $30 → $4 Downgrades Buy → Hold
03/13/2020 2492.59% Goldman Sachs → $28 Upgrades Neutral → Buy
03/02/2020 2029.63% Cowen & Co. → $23 Initiates Coverage On → Outperform
02/26/2020 1011.11% Oppenheimer $13 → $12 Maintains Underperform
02/18/2020 2122.22% Citigroup $27 → $24 Upgrades Neutral → Buy
01/06/2020 1937.04% JP Morgan → $22 Initiates Coverage On → Neutral
12/16/2019 640.74% Oppenheimer $7 → $8 Maintains Underperform
12/16/2019 2307.41% Stifel $28 → $26 Downgrades Buy → Hold
11/20/2019 548.15% Oppenheimer → $7 Initiates Coverage On → Underperform
11/18/2019 2400% Citigroup $23 → $27 Downgrades Buy → Neutral
10/31/2019 2029.63% Aegis Capital → $23 Initiates Coverage On → Buy
10/15/2019 1474.07% Goldman Sachs → $17 Initiates Coverage On → Neutral
03/22/2019 2400% Stifel → $27 Initiates Coverage On → Buy
11/02/2018 2492.59% Citigroup $25 → $28 Downgrades Buy → Neutral
10/17/2018 2214.81% Citigroup $17 → $25 Maintains Buy
09/25/2018 1288.89% Jefferies $7 → $15 Maintains Buy
09/25/2018 1474.07% Citigroup $5 → $17 Maintains Buy
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
07/20/2023 -7.41% 高盛 $1.5→$1 維護
07/19/2023 15.74% 北國資本市場 $2→$1.25 維護 市場表現
01/06/2023 177.78% 傑富瑞 $1.3→$3 升級 持有→購買
10/19/2022 85.19% SVB Leerink $3→$2 維護 市場表現
2022年05月24日 38.89% 高盛 $1.75→$1.5 維護
05/06/2022 - 摩根大通 評級下調 中性→減持
05/05/2022 177.78% HC Wainwright公司 $10→$3 評級下調 購買→中性
05/05/2022 177.78% SVB Leerink $10→$3 評級下調 跑贏→市場表現
02/16/2022 825.93% SVB Leerink $11→$10 維護 跑贏大盤
2022年1月31日 918.52% SVB Leerink $12→$11 維護 跑贏大盤
09/09/2021 1011.11% SVB Leerink →$12 開始承保 →跑贏大盤
2021/05/12 362.96% 高盛 $6→$5 評級下調 中性→銷售
02/01/2021 1381.48% SVB Leerink $12→$16 維護 跑贏大盤
09/28/2020 1011.11% SVB Leerink $9→$12 維護 跑贏大盤
2020/08/26 1844.44% 派珀·桑德勒 →$21 開始承保 →超重
05/04/2020 918.52% 宙斯盾資本 $9→$11 維護
05/04/2020 733.33% SVB Leerink $7→$9 維護 跑贏大盤
04/01/2020 455.56% 花旗集團 $24→$6 維護
03/31/2020 640.74% Stifel $24→$8 維護 保持
03/31/2020 - 奧本海默 升級 表現遜於→表現
03/31/2020 270.37% 高盛 $27→$4 評級下調 購買→中性
03/31/2020 270.37% 傑富瑞 $30→$4 評級下調 購買→Hold
03/13/2020 2492.59% 高盛 →$28 升級 中性→購買
03/02/2020 2029.63% 考恩公司 →$23 開始承保 →跑贏大盤
02/26/2020 1011.11% 奧本海默 $13→$12 維護 表現不佳
02/18/2020 2122.22% 花旗集團 $27→$24 升級 中性→購買
01/06/2020 1937.04% 摩根大通 →$22 開始承保 →中性
2019年12月16日 640.74% 奧本海默 $7→$8 維護 表現不佳
2019年12月16日 2307.41% Stifel $28→$26 評級下調 購買→Hold
2019年11月20日 548.15% 奧本海默 →$7 開始承保 →表現不佳
2019年11月18日 2400% 花旗集團 $23→$27 評級下調 購買→中性
2019年10月31日 2029.63% 宙斯盾資本 →$23 開始承保 →購買
2019年10月15日 1474.07% 高盛 →$17 開始承保 →中性
2019/03/22 2400% Stifel →$27 開始承保 →購買
11/02/2018 2492.59% 花旗集團 $25→$28 評級下調 購買→中性
2018年10月17日 2214.81% 花旗集團 $17→$25 維護
2018年09月25日 1288.89% 傑富瑞 $7→$15 維護
2018年09月25日 1474.07% 花旗集團 $5→$17 維護

What is the target price for Amarin Corp (AMRN)?

Amarin Corp(AMRN)的目標價是多少?

The latest price target for Amarin Corp (NASDAQ: AMRN) was reported by Goldman Sachs on July 20, 2023. The analyst firm set a price target for $1.00 expecting AMRN to fall to within 12 months (a possible -7.41% downside). 4 analyst firms have reported ratings in the last year.

高盛於2023年7月20日報道了阿瑪林公司(納斯達克代碼:AMRN)的最新目標價。這家分析公司將目標價定為1.00美元,預計amrn將在12個月內下跌(可能下跌7.41%)。去年有4家分析公司公佈了評級。

What is the most recent analyst rating for Amarin Corp (AMRN)?

分析師對Amarin Corp(AMRN)的最新評級是多少?

The latest analyst rating for Amarin Corp (NASDAQ: AMRN) was provided by Goldman Sachs, and Amarin Corp maintained their sell rating.

高盛對Amarin Corp(納斯達克代碼:AMRN)的最新分析師評級為賣出,Amarin Corp維持賣出評級。

When is the next analyst rating going to be posted or updated for Amarin Corp (AMRN)?

Amarin Corp(AMRN)的下一次分析師評級將於何時發佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Amarin Corp, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Amarin Corp was filed on July 20, 2023 so you should expect the next rating to be made available sometime around July 20, 2024.

分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公共財務報表,與Amarin公司的高管和客戶交談,以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。Amarin Corp的上一次評級是在2023年7月20日提交的,所以你應該預計下一次評級將在2024年7月20日左右的某個時候公佈。

Is the Analyst Rating Amarin Corp (AMRN) correct?

分析師對Amarin Corp(AMRN)的評級正確嗎?

While ratings are subjective and will change, the latest Amarin Corp (AMRN) rating was a maintained with a price target of $1.50 to $1.00. The current price Amarin Corp (AMRN) is trading at is $1.08, which is out of the analyst's predicted range.

雖然評級是主觀的,並將發生變化,但最新的Amarin Corp(AMRN)評級維持不變,目標價在1.50美元至1.00美元之間。Amarin公司目前的股價為1.08美元,超出了分析師的預期區間。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論